<p>PW MEDTECH (01358.HK) announced that its subsidiary Sichuan Ruijian Medical (874652.NEEQ) achieved a revenue of 615 million RMB for the fiscal year 2025, an increase of 27.2% year-on-year. The net profit attributable to shareholders was 151 million RMB, a growth of 18%</p>

01358

512290

588250

<p>PW MEDTECH announced that its subsidiary Sichuan Ruijian Medical (874652.NEEQ) achieved a revenue of RMB 615 million for the fiscal year 2025, an increase of 27.2% year-on-year. The net profit attributable to shareholders was RMB 151 million, a growth of 18%</p>

AASTOCKS

PW MEDTECH

Guotai CSI Bio-medicine ETF

Penghua SSE STAR Biology and Medicine ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Tianhong CNI BIOMEDICINE ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

ChinaAMC CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Minsheng Royal CSI Biotechnology Theme ETF

ICBCCS SSE STAR Biology and Medicine ETF

ChinaAMC CSI All Share Health Care Devices ETF

PW MEDTECH's subsidiary Sichuan Ruijian Medical earned 151 million RMB last year, an increase of 18%